Paediatric Measles in Romania: A Comparative Clinical and Epidemiological Analysis of the 2017-2019 and 2023-2024 Epidemic Waves at a Tertiary Care Centre in Bucharest.

Publication date: May 26, 2025

Measles remains a major public health issue, particularly among paediatric populations who are unvaccinated or lack of maternal antibody transfer. Although the majority of cases manifest with moderate clinical forms, certain patient categories are at risk for severe disease progression. This study aims to describe the clinical and epidemiological characteristics of paediatric measles cases hospitalized in the Paediatric Departments of the “Prof. Dr. Matei Balș” National Institute of Infectious Diseases, Bucharest, Romania during two distinct epidemic waves: 2017-2019 and 2023-2024. A retrospective analysis evaluated mortality rates, distribution by age and sex, as well as clinical disease patterns. The 2023-2024 measles epidemic was marked by a higher number of paediatric cases (3. 114 vs. 1. 068), a lower mortality rate (0. 32% vs. 3. 74%), a shift towards older age groups, and a greater frequency of complications-particularly gastrointestinal, haematological, and ophthalmological-compared to the 2017-2019 wave. The findings underscore the urgent need for strengthened vaccination programs and targeted public health interventions, particularly among vulnerable groups and patients at risk of developing severe forms of the disease. Owing to a sustained decline in measles vaccination coverage among the paediatric population, Romania has experienced two major measles outbreaks within the past decade, interrupted by the COVID-19 pandemic. This study draws attention to the increasing incidence of measles in older children, suggesting a cumulative effect of reduced immunization rates over time.

Open Access PDF

Concepts Keywords
Gastrointestinal Adolescent
Romania Child
Vaccination Child, Preschool
Viruses children
clinical forms
complications
Disease Outbreaks
Epidemics
Female
Hospitalization
Humans
Infant
Male
Measles
measles
Measles Vaccine
Measles Vaccine
Retrospective Studies
Romania
Romania
Tertiary Care Centers
Vaccination

Semantics

Type Source Name
disease MESH Measles
pathway KEGG Measles
disease MESH disease progression
drug DRUGBANK Dimercaprol
disease MESH Infectious Diseases
disease MESH complications
disease MESH COVID-19 pandemic
pathway REACTOME Infectious disease
disease IDO infectious disease
disease IDO country
disease IDO contagiousness
disease MESH maculopapular exanthem
disease MESH fatal outcomes
disease IDO host
disease MESH pneumonia
disease MESH bronchopneumonia
disease MESH pleural effusion
disease MESH bronchiolitis
disease MESH respiratory failure
disease MESH dehydration
disease MESH syndrome
disease MESH hepatitis
disease MESH pancreatitis
disease MESH stomatitis
disease MESH otitis
disease MESH croup
disease MESH laryngitis
disease MESH keratoconjunctivitis
disease MESH meningitis
disease MESH encephalitis
disease MESH myelitis
disease MESH subacute sclerosing panencephalitis
disease MESH death
disease IDO susceptible population
disease MESH malnutrition
disease IDO immunosuppression
disease MESH infection
disease MESH vitamin deficiency
disease MESH asthma
pathway KEGG Asthma
disease MESH multiple organ failure
disease MESH conjunctivitis
disease IDO pathogen
disease IDO blood

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *